简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-07-29 09:36 Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable Drug Delivery
2021-07-29 09:34 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
2021-07-29 09:33 ENYO Pharma Announces Positive Vonafexor (EYP001) Results for the LIVIFY Phase 2a Study in F2-F3 NASH Patients over 12 weeks
2021-07-28 13:21 SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis
2021-07-27 15:10 Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link Between Eye Health and Sustainable Development
2021-07-26 16:25 Wyss Center Partners With Artiria Medical to Accelerate a Novel Therapy for Cerebral Vasospasm
2021-07-26 16:02 Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China
2021-07-26 15:46 Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
2021-07-26 09:29 Merck Announces Appointment of Head of China & International for Healthcare
2021-07-23 16:47 rf IDEAS to Showcase Collaboration with Healthcare Partners at HIMSS21
2021-07-21 12:06 Crown Bioscience Invests in Commercial Leadership
2021-07-21 08:42 Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
2021-07-20 14:50 Seoul Viosys’ Violeds Technology Proves 99% Disinfection of COVID-19 Delta Variant in a Second to Support Airborne Viruses Prevention
2021-07-20 14:45 CSOP to Bring CSOP China Healthcare Disruption Index ETF (stock ticker: 3174.HK) to List on the HKEX
2021-07-20 14:19 Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange
2021-07-20 12:10 Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
2021-07-19 19:04 Celltrion’s Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates Strong Neutralising Activity Against Delta Variant
2021-07-19 09:01 ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs
2021-07-15 16:18 iNova Pharmaceuticals Earns the Best Place To Work Global Certification
2021-07-15 15:02 NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic

Business Wire Weibo

Press Releases

Latest Releases